Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2

Add time:07/20/2019    Source:sciencedirect.com

SummaryCisplatin is classically known to exhibit anticancer activity through DNA damage in the nucleus. Here we found a mechanism by which cisplatin affects iron metabolism, leading to toxicity and cell death. Cisplatin causes intracellular iron deficiency through direct inhibition of the master regulator of iron metabolism, iron regulatory protein 2 (IRP2) with marginal effects on IRP1. Cisplatin, but not carboplatin or transplatin, binds human IRP2 at Cys512 and Cys516 and impairs IRP2 binding to iron-responsive elements of ferritin and transferrin receptor-1 (TfR1) mRNAs. IRP2 inhibition by cisplatin caused ferritin upregulation and TfR1 downregulation leading to sustained intracellular iron deficiency. Cys512/516Ala mutant IRP2 made cells more resistant to cisplatin. Furthermore, combination of cisplatin and the iron chelator desferrioxamine enhanced cytotoxicity through augmented iron depletion in culture and xenograft mouse model. Collectively, cisplatin is an inhibitor of IRP2 that induces intracellular iron deficiency.

We also recommend Trading Suppliers and Manufacturers of iron(+2) cation (cas 10179-73-4). Pls Click Website Link as below: cas 10179-73-4 suppliers

Prev:Removal of heavy metals by electrocoagulation from hydrogenocarbonate-containing waters: Compared cases of divalent iron and zinc cations
Next:On Piroxicam degradation by homogeneous Fenton’s reaction and the influence of iron cations complexation)